Lv4
424 积分 2025-11-08 加入
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
32分钟前
已完结
[fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification
37分钟前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
1小时前
已完结
DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance
1小时前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
1小时前
已完结
Selection and in vitro characterization of human CD44v6‐binding antibody fragments
26天前
已完结
Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
1个月前
已完结
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α
1个月前
已完结
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α
1个月前
已完结
An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy
1个月前
已完结
皖公网安备34019202002308
